Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lye

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Antimicrobial Agents|December 13, 2016
Prosthetic joints: shining lights on challenging blind spotsKordo Saeed, Matthew Dryden, Matteo Bassetti, et al.
Research Square|March 2, 2022
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecovirusesLin-Fa Wang, Chee Wah Tan, Wan Ni Chia, et al.
Hlife|July 12, 2024
Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individualsChee Wah Tan, Feng Zhu, Wan Ni Chia, et al.
Nature Communications|January 18, 2024
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severityQuy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M Gamage, et al.
Infectious Diseases and Therapy|September 4, 2022
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy AdultsVenkateshan S Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, et al.
Singapore Medical Journal|April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learntJun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
Open Forum Infectious Diseases|July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant <i>Staphylococcus aureus</i> (CAMERA2) Trial: A Post Hoc AnalysisAmy Legg, Matthew A Roberts, Jane Davies, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Antimicrobial Agents|December 13, 2016
Prosthetic joints: shining lights on challenging blind spotsKordo Saeed, Matthew Dryden, Matteo Bassetti, et al.
Research Square|March 2, 2022
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecovirusesLin-Fa Wang, Chee Wah Tan, Wan Ni Chia, et al.
Hlife|July 12, 2024
Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individualsChee Wah Tan, Feng Zhu, Wan Ni Chia, et al.
Nature Communications|January 18, 2024
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severityQuy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M Gamage, et al.
Infectious Diseases and Therapy|September 4, 2022
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy AdultsVenkateshan S Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, et al.
Singapore Medical Journal|April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learntJun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
Open Forum Infectious Diseases|July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant <i>Staphylococcus aureus</i> (CAMERA2) Trial: A Post Hoc AnalysisAmy Legg, Matthew A Roberts, Jane Davies, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Pageof 4